Gus has run several clinical trials in glaucoma surgery. His research interests include angle closure glaucoma, randomised controlled trials of glaucoma treatments, and anterior segment imaging.
For a comprehensive listing of Professor Gazzard’s research and publications see his listing on the ORCID website here.
Professor Gazzard was part of the world’s first randomised controlled trial to prove the effectiveness of the PRESERFLO™ MicroShunt Glaucoma Drainage System. Read more
He has the largest amount of experience in the U.K. and Europe with Hydrus micro-stent procedures, with around 300 devices implanted. Read more
Professor Gazzard in a leading author of multiple publications on Minimally Invasive Glaucoma Surgery (MIGS) including influential Cochrane meta-analyses of all the available studies Read more
He led the world’s largest, pivotal and highly influential study proving laser can be safely and effectively used for newly diagnosed open angle glaucoma patients as in the ground-breaking Selective Laser Trabeculoplasty (SLT) study. Read more
He has authored over 110 publications, and is currently working as the chief investigator on the LiGHT SLT Trial.
Prof. Gazzard is the author of ’this definitive review of the data on the main treatment for angle closure. You can read this ground-breaking paper on his research here
His particular areas of research are the diagnosis and surgical management of glaucoma and cataracts, with a particular interest in randomised controlled trials of treatment as well as the epidemiology and prevention of myopia.
Research experience includes:
Research into laser alternatives to drop treatments (laser trabeculoplasty, SLT), angle closure glaucoma and randomised controlled trials of treatment.
Two years research into the diagnosis and management of glaucoma ~ Institute of Ophthalmology, London and Singapore National Eye Centre leading to MD Thesis (2006, UCL)
Two year Surgical Glaucoma Fellowship ~ Moorfields